4.7 Article

Increased Microglial Exosomal miR-124-3p Alleviates Neurodegeneration and Improves Cognitive Outcome after rmTBI

期刊

MOLECULAR THERAPY
卷 28, 期 2, 页码 503-522

出版社

CELL PRESS
DOI: 10.1016/j.ymthe.2019.11.017

关键词

-

资金

  1. National Natural Science Foundation of China [81501055, 81772060, 81720108015, 81671221]
  2. Tianjin Municipal Science and Technology Commission Natural Fund Project [18JCQNJC81100]

向作者/读者索取更多资源

Repetitive mild traumatic brain injury (rmTBI) is considered to be an important risk factor for long-term neurodegenerative disorders such as Alzheimer's disease, which is characterized by beta-amyloid abnormalities and impaired cognitive function. Microglial exosomes have been reported to be involved in the transportation, distribution, and clearance of beta-amyloid in Alzheimer's disease. However, their impacts on the development of neurodegeneration after rmTBI are not yet known. The role of miRNAs in microglial exosomes on regulating post-traumatic neurodegeneration was investigated in the present study. We demonstrated that miR-124-3p level in microglial exosomes from injured brain was significantly altered in the acute, sub-acute, and chronic phases after rmTBI. In in vitro experiments, microglial exosomes with upregulated miR-124-3p (EXO-124) alleviated neurodegeneration in repetitive scratch-injured neurons. The effects were exerted by miR-124-3p targeting Rela, an inhibitory transcription factor of ApoE that promotes the beta-amyloid proteolytic breakdown, thereby inhibiting beta-amyloid abnormalities. In mice with rmTBI, the intravenously injected microglial exosomes were taken up by neurons in injured brain. Besides, miR-124-3p in the exosomes was transferred into hippocampal neurons and alleviated neurodegeneration by targeting the Rela/ApoE signaling pathway. Consequently, EXO-124 treatments improved the cognitive outcome after rmTBI, suggesting a promising therapeutic strategy for future clinical translation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Peripheral Monocyte Percentage as a Potential Indicator of Prognosis in Patients with Chronic Subdural Hematoma Receiving Conservative Therapy

Dong Wang, Yueshan Fan, Yibing Fan, Zengguang Wang, Liang Yang, Jinhao Huang, Chuang Gao, Zilong Zhao, Jianning Zhang, Rongcai Jiang

Summary: The percentage of monocytes in peripheral blood may be a convenient and effective indicator for predicting the outcome of CSDH in patients receiving conservative treatment. Patients with good outcomes had obviously lower circulating monocyte percentages in their peripheral blood counts throughout the treatment period, and the monocyte percentage was also significantly decreased in patients who responded well to atorvastatin combined with dexamethasone.

WORLD NEUROSURGERY (2022)

Article Neurosciences

Modafinil Reduces Neuronal Pyroptosis and Cognitive Decline After Sleep Deprivation

Xiangyang Xiong, Yan Zuo, Lu Cheng, Zhenyu Yin, Tianpeng Hu, Mengtian Guo, Zhaoli Han, Xintong Ge, Wenzhu Li, Yan Wang, Dong Wang, Conglin Wang, Lan Zhang, Yaodan Zhang, Qiang Liu, Fanglian Chen, Ping Lei

Summary: This study found that modafinil improves learning and memory, reduces inflammation, and inhibits neuronal pyroptosis. It also upregulates brain-derived neurotrophic factor and synaptic activity. These findings suggest that modafinil can alleviate cognitive decline following sleep deprivation.

FRONTIERS IN NEUROSCIENCE (2022)

Article Endocrinology & Metabolism

Effects of increased intracranial pressure on cerebrospinal fluid influx, cerebral vascular hemodynamic indexes, and cerebrospinal fluid lymphatic efflux

Tangtang Xiang, Dongyi Feng, Xinjie Zhang, Yupeng Chen, Hanhua Wang, Xuanhui Liu, Zhitao Gong, Jiangyuan Yuan, Mingqi Liu, Zhuang Sha, Chuanxiang Lv, Weiwei Jiang, Meng Nie, Yibing Fan, Di Wu, Shiying Dong, Jiancheng Feng, Eugene D. Ponomarev, Jianning Zhang, Rongcai Jiang

Summary: This study found that increased intracranial pressure significantly impacts the glymphatic-lymphatic fluid transport system (GLFTS), and this impact depends on the severity of the intracranial pressure. These findings have translational applications in the prevention and treatment of related neurological disorders.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2022)

Article Immunology

Mesenchymal stromal cell treatment attenuates repetitive mild traumatic brain injury-induced persistent cognitive deficits via suppressing ferroptosis

Dong Wang, Shishuang Zhang, Xintong Ge, Zhenyu Yin, Meimei Li, Mengtian Guo, Tianpeng Hu, Zhaoli Han, Xiaodong Kong, Dai Li, Jing Zhao, Lu Wang, Qiang Liu, Fanglian Chen, Ping Lei

Summary: This study found that repetitive mild traumatic brain injury (rmTBI) leads to changes in biomarker levels related to ferroptosis, and treatment with mesenchymal stromal cells (MSCs) can alleviate neuronal damage and improve cognitive function caused by rmTBI, partially through inhibiting ferroptosis.

JOURNAL OF NEUROINFLAMMATION (2022)

Article Clinical Neurology

Craniocervical Manual Lymphatic Drainage Increases the Efficiency of Atorvastatin-Based Treatment of Chronic Subdural Hematoma

Chuang Gao, Yingsheng Wei, Xinjie Zhang, Jinhao Huang, Meng Nie, Xuanhui Liu, Jiangyuan Yuan, Dong Wang, Ye Tian, Weiwei Jiang, Shuo An, Jian Sun, Zhuang Sha, Yibing Fan, Jiancheng Feng, Mingqi Liu, Shiying Dong, Di Wu, Jianning Zhang, Junping Wang, Rongcai Jiang

Summary: The objective of this study was to investigate the effects of craniocervical manual lymphatic drainage (cMLD) on hematoma absorption and the efficiency of atorvastatin-based conservative treatment in patients with chronic subdural hematoma (CSDH). The results showed that cMLD, combined with atorvastatin-based therapy, promoted hematoma absorption and reduced the need for surgery. The volume of the deep cervical lymphatic nodes (dCLNs) also significantly increased after 2 weeks of cMLD treatment. No severe side effects were reported.

TRANSLATIONAL STROKE RESEARCH (2023)

Article Neurosciences

MicroRNA alteration in cerebrospinal fluid from comatose patients with traumatic brain injury after right median nerve stimulation

Ying Jia, Yi-fan He, Ye Tian, Yuan-zhi Wang, Rui-ting Zhao, Xiao-chun Li, Jian Sun, Ying-sheng Wei, Shuo An, Heng-jie Yuan, Chun-xiao Wan, Rong-cai Jiang

Summary: Electrical stimulation of the right median nerve can aid in coma arousal after traumatic brain injury. This study investigated the efficacy of this stimulation and explored the mechanisms behind it. The results showed that patients who received right median nerve electrical stimulation experienced a more rapid increase in awareness and brain function. The analysis of microRNA expression revealed a relationship between differentially expressed microRNAs and neuronal growth, repair, and neural signal transmission. The pathways most correlated with these microRNAs were associated with tumor necrosis factor signaling and dopaminergic synapse.

EXPERIMENTAL BRAIN RESEARCH (2022)

Review Clinical Neurology

Possible mechanism and Atorvastatin-based treatment in cupping therapy-related subdural hematoma: A case report and literature review

Tangtang Xiang, Xinjie Zhang, Yingsheng Wei, Dongyi Feng, Zhitao Gong, Xuanhui Liu, Jiangyuan Yuan, Weiwei Jiang, Meng Nie, Yibing Fan, Yupeng Chen, Jiancheng Feng, Shiying Dong, Chuang Gao, Jinhao Huang, Rongcai Jiang

Summary: This study reports three cases of SDH that may be associated with substandard cupping therapy and Intracranial Pressure Reduction (ICPR). The patients experienced severe headaches after the cup placed on the occipital-neck junction (ONJ) was suddenly removed during the last cupping procedure, and were diagnosed with SDH the next day. It is speculated that the repeated removal of cups on the soft tissue over the cisterna magna created localized negative pressure, causing temporary but repeated ICPR and eventually leading to SDH development. This case serves as a reminder for professional technicians to assess the patient's condition before cupping therapy and to ensure proper placement of the cups.

FRONTIERS IN NEUROLOGY (2022)

Article Clinical Neurology

Establishment and validation of a prediction model for self-absorption probability of chronic subdural hematoma

Ye Tian, Dong Wang, Xinjie Zhang, Huijie Wei, Yingsheng Wei, Shuo An, Chuang Gao, Jinhao Huang, Jian Sun, Rongcai Jiang, Jianning Zhang

Summary: A new prediction model for the self-absorption probability of chronic subdural hematoma (CSDH) was established and validated. The model showed good performance in both the initial data and external validation.

FRONTIERS IN NEUROLOGY (2022)

Article Medical Laboratory Technology

The inflammatory cellular feature in the peripheral blood of chronic subdural hematoma patients

Yibing Fan, Di Wu, Xinjie Zhang, Weiwei Jiang, Meng Nie, Xuanhui Liu, Tangtang Xiang, Mingqi Liu, Yupeng Chen, Dongyi Feng, Jinhao Huang, Chuang Gao, Rongcai Jiang

Summary: By comparing the data of CSDH patients and control individuals, it was found that the inflammatory markers of CSDH patients were significantly higher than those of the control group. After being cured, the number of inflammatory cells in patients decreased, suggesting the existence of a non-hematologic route for hematoma absorption.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2022)

Article Oncology

A novel compound EPIC-0412 reverses temozolomide resistance via inhibiting DNA repair/MGMT in glioblastoma

Jixing Zhao, Shixue Yang, Xiaoteng Cui, Qixue Wang, Eryan Yang, Fei Tong, Biao Hong, Menglin Xiao, Lei Xin, Can Xu, Yanli Tan, Chunsheng Kang

Summary: Researchers have discovered a small-molecule inhibitor called EPIC-0412 that enhances the effectiveness of the chemotherapy drug TMZ in treating GBM. By disrupting DNA damage repair pathways and targeting MGMT, EPIC-0412 sensitizes GBM cells to TMZ and induces cell cycle arrest and apoptosis. The study also shows that EPIC-0412 epigenetically silences MGMT through specific pathways.

NEURO-ONCOLOGY (2023)

Editorial Material Oncology

Bridging deep sequencing to precision oncology in meningiomas

Xing Liu, Chunsheng Kang

NEURO-ONCOLOGY (2023)

Article Geriatrics & Gerontology

Potential blood biomarkers for chronic traumatic encephalopathy: The multi-omics landscape of an observational cohort

Xintong Ge, Mengtian Guo, Meimei Li, Shishuang Zhang, Junlian Qiang, Luoyun Zhu, Lu Cheng, Wenzhu Li, Yan Wang, Jinwen Yu, Zhenyu Yin, Fanglian Chen, Wen Tong, Ping Lei

Summary: Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease associated with repetitive head impacts, which is common in elderly people, athletes of full contact sports, military personnel, and victims of domestic violence. A diagnostic framework for CTE was proposed in 2021, but the clinical diagnostic criteria still need to be refined and validated with in vivo biomarkers. Tianjin Medical University General Hospital has conducted an observational cohort study since 2021, identifying potential CTE biomarkers in blood and exosomes. These biomarkers may contribute to updating the consensus diagnostic criteria for CTE.

FRONTIERS IN AGING NEUROSCIENCE (2022)

Article Oncology

EPIC-0307-mediated selective disruption of PRADX-EZH2 interaction and enhancement of temozolomide sensitivity to glioblastoma via inhibiting DNA repair and MGMT

Lei Xin, Yanli Tan, Yuanxue Zhu, Xiaoteng Cui, Qixue Wang, Jixing Zhao, Shaohui Tian, Can Xu, Menglin Xiao, Biao Hong, Jianglong Xu, Xiaoye Yuan, Changsheng Wang, Chunsheng Kang, Chuan Fang

Summary: This study identified a potential small-molecule inhibitor, EPIC-0307, that selectively disrupted the PRADX-EZH2 interaction to upregulate expressions of tumor suppressor genes, thereby exerting its antitumor effects on GBM cells. EPIC-0307 treatment also increased the chemotherapeutic efficacy of TMZ by epigenetically downregulating DNA repair-associated genes and MGMT expression in GBM cells.

NEURO-ONCOLOGY (2023)

Review Oncology

Expert opinion on translational research for advanced glioblastoma treatment

Xiaoteng Cui, Yunfei Wang, Junhu Zhou, Qixue Wang, Chunsheng Kang

Summary: Malignant gliomas are difficult to diagnose and treat due to their infiltrative growth pattern, rapid progression, and poor prognosis. Temozolomide (TMZ) is the only first-line chemotherapeutic drug for malignant gliomas that can cross the blood-brain barrier, but some patients are insensitive to TMZ and can develop acquired resistance during treatment.

CANCER BIOLOGY & MEDICINE (2023)

Article Neurosciences

Intranasal Delivery of Gene-Edited Microglial Exosomes Improves Neurological Outcomes after Intracerebral Hemorrhage by Regulating Neuroinflammation

Mengtian Guo, Xintong Ge, Conglin Wang, Zhenyu Yin, Zexi Jia, Tianpeng Hu, Meimei Li, Dong Wang, Zhaoli Han, Lu Wang, Xiangyang Xiong, Fanglian Chen, Ping Lei

Summary: Genetically modified microglial exosomes showed potential therapeutic effects in reducing neuro-deficits and brain edema, improving blood-brain barrier integrity, and reducing neural cell death in intracerebral hemorrhage (ICH) mice. This provides a promising therapeutic strategy for improving neuroinflammation in ICH.

BRAIN SCIENCES (2023)

暂无数据